- CA$465.54m
- CA$336.08m
- CA$108.64m
- 74
- 75
- 77
- 89
2019 October 31st | 2020 October 31st | 2021 October 31st | 2022 October 31st | 2023 October 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Interest Income | |||||
Interest Expense | |||||
Net Interest Income | 53.9 | 54.1 | 60.2 | 76.7 | 100 |
Loan Loss Provision | |||||
Net Interest Income After Loan Loss Provision | 54.2 | 54.5 | 60.6 | 76.2 | 99.4 |
Non Interest Income | |||||
Non Interest Expense | |||||
Net Income Before Taxes | 27.8 | 26.8 | 30.8 | 32.5 | 57.6 |
Provision for Income Taxes | |||||
Net Income After Taxes | 20.2 | 19.4 | 22.4 | 22.7 | 42.2 |
Net Income Before Extraordinary Items | |||||
Net Income | 20.2 | 19.4 | 22.4 | 22.7 | 42.2 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 18 | 17.2 | 20.8 | 21.7 | 41.2 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.852 | 0.816 | 0.956 | 0.79 | 1.57 |
Dividends per Share |